Cell culture medium additives and their uses
A water-soluble vinyl polymer with betaine structures in its side chain enhances antibody and enzyme production in cell culture media, addressing the inefficiencies of serum-free media and reducing costs.
Patent Information
- Application Number
- JP2021103070
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-06-24
- Filing Date
- 2021-06-22
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2041-06-22
AI Technical Summary
Conventional serum-free media are not as effective as serum-containing media in terms of cell proliferation, survival, and antibody productivity, and existing betaine polymers do not address the productivity of physiologically active substances per amount of DNA.
A cell culture medium additive containing a water-soluble vinyl polymer with specific structural units, including betaine structures in its side chain, is used to enhance the production of physiologically active substances without increasing cost or labor.
The additive increases the productivity of substances like antibodies and drug-metabolizing enzymes, reduces manufacturing costs, and improves cell activity and spheroid formation, contributing to the mass supply of biopharmaceuticals.
Smart Images

Figure 0007589650000001 
Figure 0007589650000002 
Figure 0007589650000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a cell culture medium additive suitable for enhancing the production of a physiologically active substance during animal cell culture. The present invention further relates to a method for producing a physiologically active substance using a medium containing the cell culture medium additive. [Background technology]
[0002] In regenerative medicine using stem cells such as iPS cells, ES cells, and mesenchymal stem cells, it is expected that these cells will be efficiently proliferated and then differentiated into target tissues for transplantation. In addition, it has become increasingly common to mass-produce useful physiologically active substances (hormones, neurotransmitters, cytokines, vitamins and minerals, enzymes, nucleic acids, etc.) such as monoclonal antibodies on an industrial scale by mass-culturing animal cells. In such cases, animal serum such as fetal bovine serum (FBS) is frequently used as a growth factor. Specifically, a culture medium in which about 10-20% animal serum such as fetal bovine serum (FBS) is added to a synthetic basal medium such as RPM11640, Eagle's MEM, or Ham's F12 is generally used.
[0003] However, adding serum such as fetal bovine serum (FBS) to culture media has the disadvantages of increasing the cost of the medium and making it difficult to isolate the desired physiologically active substances from the culture medium containing serum-derived proteins. In addition, there is often variation in quality between lots of serum. Therefore, it is necessary to thoroughly check the lot before using serum and select a serum that can be used, but this selection of serum requires a lot of effort.
[0004] In order to solve the above problems, medium additives that can improve the efficiency of cell culture and reduce costs have been investigated. For example, Patent Document 1 discloses that the addition of glycylglycine to a medium can cause animal cells to produce useful substances at high concentrations. Furthermore, Patent Document 2 discloses that when cells are cultured in a medium containing a polymer having a structure similar to phospholipids, a physiologically active substance can be efficiently produced. Furthermore, Patent Document 3 discloses that a medium containing a hydrophobic D-amino acid promotes cell growth and increases the production of useful substances. In addition, as a study focusing on betaine polymers similar to those of the present invention, Patent Document 4 discloses a protein aggregation inhibitor containing a sulfobetaine polymer as an active ingredient. Patent Document 5 discloses a non-adhesive material for biological materials containing a sulfobetaine polymer. And Patent Document 6 discloses a medical material containing a carbobetaine polymer. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] Japanese Patent Application Publication No. 7-23780 [Patent Document 2] Japanese Patent Application Publication No. 4-304882 [Patent Document 3] JP 2015-027265 A [Patent Document 4] International Publication No. WO2016 / 181975 [Patent Document 5] Patent No. 6353923 [Patent Document 6] Patent No. 4961133 Summary of the Invention [Problem to be solved by the invention]
[0006] However, many of the conventional serum-free media are not sufficient in terms of proliferation, survival and antibody productivity of antibody-producing cells, as compared with serum-containing media. In addition, Patent Documents 4 to 6 disclose betaine polymers as in the present invention, but they do not focus on the cell activity and productivity of physiologically active substances per DNA amount that are taken up in the present invention.
[0007] In view of the above circumstances, an object of the present invention is to provide a medium additive for antibody-producing cells, which increases antibody productivity without increasing costs or labor, a method for culturing antibody-producing cells using the additive, a cell medium, and a method for producing an antibody. [Means for solving the problem]
[0008] That is, the present invention relates to any one of the following inventions. The present invention relates to a cell culture medium additive comprising a water-soluble vinyl polymer (a) having at least any one of the structural units represented by the following general formulas 1 to 3 in its side chain. [ka] [ka] [ka] (In the formula, R2 is an alkylene group having 1 to 6 carbon atoms. R3 and R4 each independently represent an alkyl group having 1 to 4 carbon atoms. R5 is an alkylene group having 1 to 4 carbon atoms. X is an oxygen atom or -NH-, Y is COO - or -SO3 - , R7 is a hydrogen atom or a methyl group. R8 is an alkylene group having 1 to 6 carbon atoms or a hydroxyalkylene group having 1 to 6 carbon atoms; R 10 ~R 14 Four of the groups represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 10 ~R 14 one of the groups represents a bonding site with the main chain of the vinyl polymer, R 15 represents an alkylene group having 1 to 6 carbon atoms or a hydroxyalkylene group having 1 to 6 carbon atoms, * indicates the bonding position with the main chain of the vinyl polymer.)
[0009] The present invention also relates to the cell culture medium additive, wherein the water-soluble vinyl polymer (a) contains 30 to 95 mass% of at least any one of the structural units represented by general formulas 1 to 3 relative to 100 mass% of the total monomer units constituting the water-soluble vinyl polymer (a).
[0010] The present invention also relates to the cell culture medium additive, wherein the water-soluble vinyl polymer (a) contains structural units based on a monomer (B) having a partition coefficient LogP of 0.8 to 10, and the structural units based on the monomer (B) account for 5 to 70 mass% relative to 100 mass% of the total monomer units constituting the water-soluble vinyl polymer (a).
[0011] The present invention relates to the above cell culture medium additive, wherein the water-soluble vinyl polymer (a) is the following (a1) or (a2): (a1) A copolymer of monomers containing at least any one of monomers (A1) to (A3) represented by the following general formulas 4 to 6. (a2) A reaction product of a copolymer of at least any one of monomers (A4) to (A6) represented by the following general formulas 7 to 9 and one or more betaining agents (D) selected from the group consisting of cyclic sulfonate esters (D1), ω-halogenated alkylsulfonate metal salts (D2), cyclic carboxylate esters (D3) and ω-halogenated alkylcarboxylate metal salts (D4). [ka] [ka] [ka] [ka] [ka] [ka] (In the formula, R1 is a hydrogen atom or a methyl group, R2 is an alkylene group having 1 to 6 carbon atoms. R3 and R4 each independently represent an alkyl group having 1 to 4 carbon atoms. R5 is an alkylene group having 1 to 4 carbon atoms. X is an oxygen atom or -NH-, Y is COO - or -SO3 - , R6 is a hydrogen atom or a methyl group. R7 is a hydrogen atom or a methyl group. R8 is an alkylene group having 1 to 6 carbon atoms or a hydroxyalkylene group having 1 to 6 carbon atoms; R 16 ~R 20 Four of the groups represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 16 ~R 20 One of them is CH2=C(R 21 ), R 15 represents an alkylene group having 1 to 6 carbon atoms or a hydroxyalkylene group having 1 to 6 carbon atoms, R 21 represents a hydrogen atom or a methyl group, ** indicates the reaction site with the betaine agent (D).
[0012] The present invention also relates to a cell culture medium comprising the cell culture medium additive.
[0013] The present invention also relates to the above cell culture medium, wherein the concentration of the water-soluble vinyl polymer (a) in the medium is 0.001 to 1% by mass.
[0014] The present invention also relates to a method for producing spheroids or a physiologically active substance, which comprises culturing cells in the cell culture medium. Effect of the Invention
[0015] The cell medium additive of the present invention can increase the production amount of a physiologically active substance when the additive is added to a cell medium and the obtained medium is used to culture cells capable of producing the physiologically active substance. In particular, the productivity of a physiologically active substance per amount of DNA can be increased. In addition, the addition of the cell medium additive of the present invention can promote the productivity of a desired physiologically active substance, which is also useful in terms of reducing production costs and labor. For example, in the case of antibodies, it can greatly contribute to mass supply in the production of biopharmaceuticals such as antibody drugs. In the case of drug-metabolizing enzymes, it can greatly contribute to drug discovery screening in pharmaceutical development. In addition, the cell culture medium additive of the present invention can be added to a cell culture medium, and the obtained medium can be used to obtain cells with excellent cell activity and spheroid formation. When cell culture is performed using the cell culture medium additive, the cell function can be improved, and therefore the additive can be used in applications such as drug discovery screening. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] The cell culture medium additive of the present invention is characterized by containing a water-soluble vinyl polymer (a).
[0017] <Water-soluble vinyl polymer (a)> In the present invention, water solubility means that the resin can be completely dissolved in water without separation or precipitation after 1 g of the resin is placed in 99 g of ion-exchanged water at 25°C, stirred, and left at 25°C for 24 hours. The betaine structure means a structure having a positive charge and a negative charge at non-adjacent positions in the same molecule, and a dissociable hydrogen atom is not bonded to the positively charged atom. The water-soluble vinyl polymer (a) means a water-soluble vinyl polymer having this betaine structure in its molecular structure. By having a hydrophilic betaine structure in the molecule, the electrostatic interaction with cells can be controlled, and the environment around the cells can be appropriately controlled, and for example, the antibody productivity of antibody-producing cells and the proliferation of established cell lines can be improved.
[0018] The water-soluble vinyl polymer (a) has at least one of the structural units represented by the following general formulas 1 to 3 in its side chain. The structural units are preferably contained in an amount of 30 to 95% by mass, and more preferably 40 to 80% by mass, relative to 100% by mass of the total monomer units constituting the water-soluble vinyl polymer (a). When in the above range, the polarity is appropriately controlled, and the cellular performance, including the cellular antibody productivity, can be further improved.
[0019] [ka]
[0020] [ka]
[0021] [ka]
[0022] (In the formula, R2 is an alkylene group having 1 to 6 carbon atoms. R3 and R4 each independently represent an alkyl group having 1 to 4 carbon atoms. R5 is an alkylene group having 1 to 4 carbon atoms. X is an oxygen atom or -NH-, Y is COO - or -SO3 - , R7 is a hydrogen atom or a methyl group. R8 is an alkylene group having 1 to 6 carbon atoms or a hydroxyalkylene group having 1 to 6 carbon atoms; R 10 ~R 14 Four of the groups represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 10 ~R 14 one of the groups represents a bonding site with the main chain of the vinyl polymer, R 15represents an alkylene group having 1 to 6 carbon atoms or a hydroxyalkylene group having 1 to 6 carbon atoms, * indicates the bonding position with the main chain of the vinyl polymer.)
[0023] Such a water-soluble vinyl polymer (a) is preferably obtained by the following method. That is, (1) At least one of the monomers (A1) to (A3) represented by the following general formulas 4 to 6 is copolymerized with other monomers as required. The resulting copolymer is called a water-soluble vinyl polymer (a1). or, (2) At least one of the monomers (A4) to (A6) represented by the following general formulas 7 to 9 is copolymerized with other monomers as required, and the moieties derived from the monomers (A4) to (A6) in the obtained copolymer are reacted with a betaining agent (D) described below. The obtained reaction product has a betaine structure like the copolymer using the monomer (A1), and is called a water-soluble vinyl polymer (a2).
[0024] [ka]
[0025] [ka]
[0026] [ka]
[0027] [ka]
[0028] [ka]
[0029] [ka]
[0030] (In the formula, R1 is a hydrogen atom or a methyl group, R6 is a hydrogen atom or a methyl group. R9 is a hydrogen atom or a methyl group. R 16 ~R 20 Four of the groups represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and R 16 ~R 20 One of them is CH2=C(R 21 ), R 21 represents a hydrogen atom or a methyl group, ** indicates the reaction site with the betaine agent (D). The other symbols are the same as those in general formulas 1 to 3.
[0031] <Water-soluble vinyl polymer (a1)> As described above, the water-soluble vinyl polymer (a1) is a copolymer having, as a structural unit thereof, at least any one of the monomers (A1) to (A3) selected from the group represented by the general formulas 4 to 6. By using the monomers (A1) to (A3), a betaine structure can be introduced into the side chain of the vinyl polymer.
[0032] <Monomer (A1)> As shown in general formula 4, the monomer (A1) has one ethylenically unsaturated group and a betaine structure in one molecule. Examples of such monomers include N-(meth)acryloyloxymethyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxyethyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxypropyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxybutyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxymethyl-N,N-diethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxyethyl-N,N-diethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxypropyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxybutyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxymethyl-N,N-diethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxypropyl-N,N-diethylammonium methyl-α-carboxybetaine, N-(meth)acryloyloxybutyl-N ,N-diethylammonium methyl-α-carboxybetaine, etc. N-(meth)acryloyloxyalkyl-N,N-dialkylammonium alkyl-α-carboxybetaine;N-(meth)acrylamidopropyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acrylamidopropyl-N,N-diethylammonium methyl-α-carboxybetaine, etc. N-(meth)acrylamidoalkyl-N,N-dialkylammonium alkyl-α-carboxybetaine;N-(meth)acrylamidopropyl-N,N-dimethylammonium methyl-α-carboxybetaine, N-(meth)acrylamidopropyl-N,N-diethylammonium methyl-α-carboxybetaine, etc. N-(meth)acrylamidoalkyl-N,N-dialkylammonium alkyl-α-carboxybetaine;N-(meth)acryloyloxymethyl-N,N-dimethylammonium methyl-α-sulfobetaine, N-(meth)acryloyloxymethyl-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxymethyl-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxymethyl-N,N-dimethylammonium butyl-α-sulfobetaine, N-(meth)acryloyloxyethyl-N,N-dimethylammonium methyl-α-sulfobetaine, N-(meth)acryloyloxyethyl-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxyethyl-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxyethyl-N,N-dimethylammonium butyl-α-sulfobetaine, N-(meth)acryloyloxypropyl-N,N-dimethyl Ammonium methyl-α-sulfobetaine, N-(meth)acryloyloxypropyl-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxypropyl-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxypropyl-N,N-dimethylammonium butyl-α-sulfobetaine, N-(meth)acryloyloxybutyl-N,N-dimethylammonium methyl-α-sulfobetaine, N-(meth)acryloyloxybutyl-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxybutyl-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxybutyl-N,N-dimethylammonium butyl-α-sulfobetaine, and other N-(meth)acryloyloxyalkyl-N,N-dimethylammonium alkyl-α-sulfobetaines;N-(meth)acryloyloxymethoxymethoxy-N,N-dimethylammonium methyl-α-sulfobetaine, N-(meth)acryloyloxymethoxymethoxy-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxymethoxymethoxy-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxymethoxymethoxy-N,N-dimethylammonium butyl-α-sulfobetaine, N-(meth)acryloyloxyethoxy N-(meth)acryloyloxyethoxyethoxy-N,N-dimethylammonium methyl-α-sulfobetaine, N-(meth)acryloyloxyethoxyethoxy-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxyethoxyethoxy-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxyethoxyethoxy-N,N-dimethylammonium butyl-α-sulfobetaine, N-(meth)acryloyloxypropoxypropoxy-N,N-dimethyl N-(meth)acryloyloxypropoxypropoxy-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxypropoxypropoxy-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxypropoxypropoxy-N,N-dimethylammonium butyl-α-sulfobetaine, N-(meth)acryloyloxybutoxybutoxy-N,N-dimethylammonium methyl- α-sulfobetaine, N-(meth)acryloyloxybutoxybutoxy-N,N-dimethylammonium ethyl-α-sulfobetaine, N-(meth)acryloyloxybutoxybutoxy-N,N-dimethylammonium propyl-α-sulfobetaine, N-(meth)acryloyloxybutoxybutoxy-N,N-dimethylammonium butyl-α-sulfobetaine, and other N-(meth)acryloyloxyalkoxyanerkoxy-N,N-dimethylammonium alkyl-α-sulfobetaines;Examples of the sulfobetaine include N-(meth)acrylamidoalkyl-N,N-dialkylammonium alkyl-α-sulfobetaine such as N-(meth)acrylamidopropyl-N,N-dimethylammonium propyl-α-sulfobetaine and N-(meth)acrylamidopropyl-N,N-dimethylammonium butyl-α-sulfobetaine. From the viewpoint of the productivity of physiologically active substances, sulfobetaine is preferred. In the present invention, the term (meth)acryl indicates methacryl or acrylic.
[0033] <Monomer (A2)> As shown in general formula 5, the monomer (A2) also has one ethylenically unsaturated group and a betaine structure in one molecule. Examples of such monomers include 1-vinyl-2-alkyl-3-(4-sulfoalkyl)imidazolium inner salts such as 1-vinyl-3-(3-sulfopropyl)imidazolium inner salt, 1-vinyl-3-(3-sulfobutyl)imidazolium inner salt, 1-vinyl-2-methyl-3-(3-sulfopropyl)imidazolium inner salt, and 1-vinyl-2-methyl-3-(4-sulfobutyl)imidazolium inner salt.
[0034] <Monomer (A3)> As shown in general formula 6, the monomer (A3) also has one ethylenically unsaturated group and a betaine structure in one molecule. Examples of such monomers include 2-vinyl-1-(3-sulfoalkyl)pyridinium inner salts such as 2-vinyl-1-(3-sulfopropyl)pyridinium inner salt and 2-vinyl-1-(3-sulfobutyl)pyridinium inner salt; and 4-vinyl-1-(3-sulfoalkyl)pyridinium inner salts such as 4-vinyl-1-(3-sulfopropyl)pyridinium inner salt and 4-vinyl-1-(3-sulfobutyl)pyridinium inner salt.
[0035] <Water-soluble vinyl polymer (a2)> As described above, the water-soluble vinyl polymer (a) in the present invention does not necessarily have to be a copolymer in which the monomers (A1) to (A3) themselves are copolymerized, and can be obtained via the following steps. That is, the water-soluble vinyl polymer (a2) can be obtained by copolymerizing at least one of the monomers (A4) to (A6) represented by the general formulas 7 to 9, which can be called the precursors of the monomers (A1) to (A3), with other monomers as required, and reacting at least a part of the nitrogens represented by ** in the obtained copolymer with the betaining agent (D). The water-soluble vinyl polymer (a2) obtained has a betaine structure in the side chain, similar to the copolymer using the monomers (A4) to (A6). It is preferable to use the betaining agent (D) so as to betaine all of the monomers (A4) to (A6).
[0036] Examples of such monomers (A4) include: N-(meth)acryloyloxymethyl-N,N-dimethylamine, N-(meth)acryloyloxyethyl-N,N-dimethylamine, N-(meth)acryloyloxypropyl-N,N-dimethylamine, N-(meth)acryloyloxybutyl-N,N-dimethylamine, N-(meth)acryloyloxymethyl-N,N-diethylamine, N-(meth)acryloyloxyethyl-N,N-diethylamine, N-(meth)acryloyloxypropyl-N,N-diethylamine, N-(meth)acryloyloxybutyl-N,N-diethylamine, N-(meth)acryloyloxyalkyl-N,N-dialkylamines such as; N-(meth)acrylamidopropyl-N,N-dimethylamine, N-(meth)acrylamidopropyl-N,N-diethylamine, N-(meth)acrylamidoalkyl-N,N-dialkylamines such as; N-(meth)acryloyloxymethoxymethoxy-N,N-dimethylamine, N-(meth)acryloyloxyethoxyethoxy-N,N-dimethylamine, N-(meth)acryloyloxypropoxypropoxy-N,N-dimethylamine, N-(meth)acryloyloxybutoxybutoxy-N,N-dimethylamine, and N-(meth)acryloyloxyalkoxyanelkoxy-N,N-dimethylamines such as these.
[0037] Examples of such monomers (A5) include: 1-vinylimidazole, 1-vinyl-2-methyl-imidazole, Examples of 1-vinyl-2-alkyl-imidazoles include 1-vinyl-2-alkyl-imidazoles such as:
[0038] Examples of such monomers (A6) include vinylpyridines such as 4-vinyl-pyridine and 2-vinyl-pyridine.
[0039] <Betaine agent (D)> The betaining agent (D) is selected from the group consisting of cyclic sulfonate (D1), ω-halogenated alkylsulfonate metal salt (D2), cyclic carboxylate (D3) and ω-halogenated alkylcarboxylate metal salt (D4). This is a group of compounds used to sulfobetaine or carbobetaine the nitrogen represented by ** in the monomers (A4) to (A6) represented by the general formulas 7 to 9 after polymerization.
[0040] Examples of such cyclic sulfonic acid esters (D1) include 1,2-ethane sultone, 1,3-propane sultone, and 1,4-butane sultone.
[0041] Examples of such ω-halogenated alkylsulfonic acid metal salts (D2) include sodium 2-chloroethanesulfonate, sodium 2-bromoethanesulfonate, sodium 3-chloropropanesulfonate, sodium 3-bromopropanesulfonate, sodium 4-chlorobutanesulfonate, and sodium 4-bromobutanesulfonate.
[0042] Examples of such cyclic carboxylates (D3) include β-propiolactone, γ-butyrolactone, and δ-valerolactone.
[0043] Examples of such ω-halogenated alkyl carboxylate metal salts (D4) include sodium 2-chloroacetate, sodium 2-bromoacetate, sodium 3-chloropropionate, sodium 3-bromopropionate, sodium 4-chlorobutyrate, sodium 4-bromobutyrate, sodium 5-chloropentanoate, and sodium 5-bromopentanoate.
[0044] <Monomer (B)> When obtaining the water-soluble vinyl polymers (a1) and (a2), in addition to the monomers (A1) to (A3) and (A4) to (A6), a monomer (B) having a partition coefficient LogP of 0.8 to 10 can be used, and the water-soluble vinyl polymer (a) preferably contains a structural unit based on the monomer (B). By introducing a structural unit based on the monomer (B), the polarity is appropriately controlled, the hydrophobic interaction with cells is controlled, and effects including the antibody productivity of cells can be maximized.
[0045] Examples of the monomer (B) having a partition coefficient LogP of 0.8 to 10 include: Alkyl ester (meth)acrylates such as methyl methacrylate, ethyl (meth)acrylate, propyl (meth)acrylate, n-butyl (meth)acrylate, pentyl (meth)acrylate, heptyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, octyl (meth)acrylate, nonyl (meth)acrylate, decyl (meth)acrylate, dodecyl (meth)acrylate, lauryl (meth)acrylate, stearyl (meth)acrylate, isostearyl (meth)acrylate, behenyl (meth)acrylate, cyclohexyl (meth)acrylate, and isobornyl (meth)acrylate; Aromatic ester (meth)acrylates such as phenyl (meth)acrylate, benzyl (meth)acrylate, and phenoxyethyl (meth)acrylate; Examples of the aromatic vinyl monomer include styrene, α-methylstyrene, 2-methylstyrene, chlorostyrene, allylbenzene, and ethynylbenzene. These may be used alone or in combination of two or more kinds.
[0046] The partition coefficient LogP is a numerical value that indicates the properties of a chemical substance, and is a constant value that does not depend on the amount added. It is the common logarithm of the concentration of each phase when the substance is in equilibrium in a mixture of water and 1-octanol, where the aqueous phase and the octanol phase are in contact with each other. When LogP is large, the substance tends to be relatively more hydrophobic, and when LogP is small, the substance tends to be relatively more hydrophilic.
[0047] LogP can generally be measured by the flask shaking method described in JIS Japanese Industrial Standards Z7260-107 (2000). LogP can also be estimated by computational chemistry methods or empirical methods instead of actual measurement. Known methods and software can be used to calculate LogP, but in the present invention, LogP is calculated using a program built into CambridgeSoft's system: ChemdrawPro11.0.
[0048] The structural units based on the monomer (B) are preferably contained in an amount of 5 to 70 mass %, more preferably 20 to 60 mass %, of the total 100 mass % of the monomer units constituting the water-soluble vinyl polymer (a). By making it 70 mass % or less, hydrophobic interaction with cells can be suppressed. By making it 5 mass % or more, the amount of the monomers (A1) to (A3) or (A4) to (A6) becomes relatively small, and the water solubility of the water-soluble vinyl polymer (a) can be appropriately suppressed.
[0049] <Monomer (C)> In obtaining the water-soluble vinyl polymers (a1) and (a2), in addition to the monomers (A1) to (A3), (A4) to (A6), and (B), a monomer (C) having a partition coefficient LogP outside the range of 0.8 to 10 can also be used. Examples of the monomer (C) having a partition coefficient LogP outside the range of 0.8 to 10 include: Hydroxyl group-containing monomers such as 2-hydroxyethyl (meth)acrylate and 2-hydroxypropyl (meth)acrylate; Carboxylic acid-containing monomers such as acrylic acid, methacrylic acid, itaconic acid, etc.; Amide group-containing monomers such as acrylamide, methacrylamide, and N,N-dimethylacrylamide; Sulfonic acid group-containing monomers such as vinyl sulfonic acid and styrene sulfonic acid; Polyethylene glycol chain-containing monomers such as polyethylene glycol (meth)acrylate and methoxypolyethylene glycol (meth)acrylate; Examples of such monomers include monomers having polar functional groups, such as phosphate group-containing monomers, such as (2-hydroxyethyl) methacrylate acid phosphate.
[0050] In the present invention, the ethylenically unsaturated bond group contained in the monomer (C) is preferably a (meth)acrylate group or an aromatic vinyl group from the viewpoint of polymerizability.
[0051] When the other monomer (C) is used, the content thereof is preferably 0 to 65 mass%, and more preferably 0 to 40 mass%, in 100 mass% of the total monomer units constituting the water-soluble vinyl polymer (a). When a monomer having a polar functional group is used as the other monomer (C), the content thereof is preferably 0 to 20 mass% in 100 mass% of the total monomer units constituting the water-soluble vinyl polymer (a). The amount of the monomer (C) is preferably small so as not to inhibit the functional expression of the betaine structure formed by reacting the portion derived from the monomers (A1) to (A3) or (A4) to (A6) with the betaine agent (D).
[0052] <Cell Culture Media> The cell culture medium to which the water-soluble vinyl polymer (a) is added may be a conventionally known cell culture medium, such as various commercially available media (αMEM, MEM, DMEM, IMDEM, RPMI1640, DMEM / F12, etc.) or a combination thereof. The concentration of the water-soluble vinyl polymer (A), which is an additive for a cell culture medium, in the culture medium is preferably 0.001 to 1 mass %, more preferably 0.01 to 1 mass %, and further preferably 0.1 to 1 mass %. It is preferable to add various growth factors (e.g., epidermal growth factor, insulin-like growth factor, nerve growth factor, hepatocyte growth factor, vascular endothelial growth factor, basic fibroblast growth factor, transferrin, steroid hormones, 2-mercaptoethanol, etc.), various animal sera (e.g., fetal bovine serum (FBS) and bovine serum), serum substitutes, etc. to the cell culture medium as necessary.
[0053] <Method of manufacturing physiologically active substances and spheroids> By culturing cells in the cell culture medium of the present invention, a physiologically active substance can be produced with high efficiency. Furthermore, by culturing cells in the cell culture medium of the present invention, spheroids can be formed.
[0054] <Physiologically active substances> The physiologically active substance according to the present embodiment is, for example, an antibody protein (hereinafter referred to as an antibody), albumin, a drug-metabolizing enzyme, etc. The antibody produced here is not particularly limited, and is, for example, a mouse monoclonal antibody, a humanized monoclonal antibody, or a human monoclonal antibody. The immunoglobulin class is not particularly limited, and is, for example, IgG (for example, IgG1, IgG2, etc.). The drug-metabolizing enzyme produced is not particularly limited, and is, for example, alcohol dehydrogenase, aldehyde dehydrogenase, glutathione peroxidase, superoxide dismutase, monoamine oxidase, diamine oxidase, epoxide hydrolase, esterase, amidase, UDP-glucuronosyltransferase, glutathione S-transferase, γ-glutamyltranspeptidase, acetyltransferase, sulfotransferase, cytochrome P450, etc. In the culture method or production method of the present invention, a vessel or device usually used for culture can be used for culture, such as a multi-well plate, a petri dish, a culture flask, a spinner flask, a jar fermenter, a fermenter, a roller bottle, a hollow fiber, a microcarrier, etc.
[0055] <cell> The cells to be cultured by the culture method of the present invention are not particularly limited as long as they are usable for producing a physiologically active substance, and examples of cells capable of producing antibodies include CHO cells, BHK cells, HepG2 cells, rodent myeloma cells (such as mouse myeloma cells, such as SP2 / O cells and NSO cells), hybridomas, insect cells, and transformed cells obtained by introducing a foreign gene into these cells, and hybridomas obtained by cell fusion of CHO cells, SP2 / O cells, NSO cells, etc. can also be used. Examples of cells capable of producing drug-metabolizing enzymes include primary hepatocytes collected from animal livers, hepatocytes induced to differentiate from stem cells, such as ES cells, iPS cells, and mesenchymal stem cells, and cell lines derived from liver cancer, such as HepG2 cells and HuH-7 cells.
[0056] The culture conditions in this embodiment may be the same as those for ordinary animal cell culture conditions, for example, conditions of 5% by volume CO2 atmosphere and a temperature of 37°C.
[0057] To harvest cells from the culture medium, suspension cells can be collected by, for example, directly centrifuging or filtering the culture medium, whereas adherent cells can be collected by, for example, suspending the cells by adding 0.25% trypsin-0.02% EDTA solution, and then centrifugally or filtering the cells.
[0058] When a physiologically active substance, particularly an antibody, produced by cell culture accumulates in the culture medium, it is collected from the supernatant obtained by filtration or centrifugation. When the substance accumulates within cells, the cells obtained by filtration or centrifugation are homogenized, sonicated, or treated with chemicals to obtain a supernatant from which the product is extracted.
[0059] The antibody can be separated and purified from the supernatant by an appropriate combination of known methods, such as ammonium sulfate precipitation, dialysis, ultrafiltration, electrophoresis, gel filtration, ion exchange chromatography, reverse phase chromatography, and affinity chromatography. EXAMPLES
[0060] The present invention will be described in more detail below with reference to examples, but the following examples are not intended to limit the scope of the invention. In the examples and comparative examples, "parts" refers to "parts by mass", "mol" refers to the amount of a substance, and "mass%" refers to the proportion of the amount of a substance in the total monomers.
[0061] <Synthesis of various betaine monomers> N-methacryloyloxyethyl-N,N-dimethylammonium butyl-α-sulfobetaine used in the synthesis of the water-soluble vinyl polymer (a) was synthesized with reference to Japanese Patent No. 5690645. Similarly, N-methacryloyloxyethyl-N,N-dimethylammonium methyl-α-carbobetaine was synthesized with reference to Japanese Patent No. 3878315, and 1-vinyl-3-(3-sulfopropyl)imidazolium inner salt and 2-vinyl-1-(3-sulfopropyl)pyridinium inner salt were synthesized with reference to Japanese Patent No. 3584998.
[0062] [Production Example 1] <Preparation of Water-Soluble Vinyl Polymer (a)> A reaction vessel equipped with a stirrer, a thermometer, a dropping funnel, and a reflux condenser was charged with 150 parts of ethanol, and the internal temperature was raised to 75°C and sufficiently replaced with nitrogen. Separately prepared 2,2'-azobis-2-methylpropionavidin 0.4 parts and N-methacryloyloxyethyl-N,N-dimethylammonium butyl-α-sulfobetaine 100 parts (100% by mass) as monomer (A1) were added dropwise for 3 hours while maintaining the internal temperature at 75°C, and stirring was continued for another 2 hours. After confirming that the conversion rate exceeded 98% by measuring the solid content, the mixture was cooled and taken out. Then, the ethanol was completely evaporated in an oven to obtain a water-soluble vinyl polymer (a). In addition, 1 g of the obtained vinyl polymer (a) was added to 99 g of ion-exchanged water at 25° C., stirred and dissolved, and then left to stand for 24 hours at 25° C. As a result, neither separation nor precipitation was observed in these resins, indicating that they were completely soluble and water-soluble.
[0063] <Preparation of cell culture medium additives> The water-soluble vinyl polymer (a) obtained above from which the solvent had been evaporated was dissolved in phosphate buffered saline (hereinafter referred to as PBS solution) to obtain a cell culture medium additive of Production Example 1 having a concentration of 10% by mass.
[0064] [Manufacturing Examples 2 to 13] Water-soluble vinyl polymers (a) were synthesized in the same manner as in Production Example 1 using the formulations shown in Table 1, and dissolved in a PBS solution to obtain cell culture medium additives of Production Examples 2 to 13.
[0065] [Table 1]
[0066] The symbols in the table are as follows: DMBS: N-methacryloyloxyethyl-N,N-dimethylammonium butyl-α-sulfobetaine DMMC: N-methacryloyloxyethyl-N,N-dimethylammonium methyl-α-carbobetaine VSPI: 1-vinyl-3-(3-sulfopropyl)imidazolium inner salt VSPP: 2-vinyl-1-(3-sulfopropyl)pyridinium inner salt BMA: Butyl methacrylate St: styrene HEA: 2-hydroxyethyl acrylate DEAA: Diethylacrylamide
[0067] [Production Example 14] A reaction vessel equipped with a stirrer, a thermometer, a dropping funnel, and a reflux condenser was charged with 150 parts of methyl ethyl ketone, and the internal temperature was raised to 75° C. and the atmosphere was fully replaced with nitrogen. A mixture of 0.4 parts of 2,2'-azobis-2-methylpropionavidin, 60 parts (60% by mass) of 2-(dimethylamino)ethyl methacrylate as monomer (A4), 30 parts (30% by mass) of butyl methacrylate as monomer (B), and 10 parts (10% by mass) of 2-hydroxyethyl acrylate as monomer (C), which had been prepared separately, was added dropwise for 3 hours while maintaining the internal temperature at 75° C., and stirring was continued for another 2 hours to obtain a copolymer. After confirming that the conversion rate exceeded 98% by solid content measurement, 47 parts of 1,3-propane sultone (equimolar amount to the monomer (A4)) as a betaine agent (D), 50 parts of ethanol, and 200 parts of ion-exchanged water were added, and stirring was continued for another 20 hours while distilling off methyl ethyl ketone and ethanol. As shown in the reaction formula below, the ring-opening reaction of 1,4-butane sultone can produce a structure derived from N-methacryloyloxyethyl-N,N-dimethylammonium butyl-α-sulfobetaine, which is a type of monomer (A1), in the side chain of a vinyl polymer.
[0068] [ka]
[0069] The mixture was then cooled, taken out, and placed in an oven to completely evaporate the solvent. In addition, 1 g of the obtained vinyl polymer (a) was added to 99 g of ion-exchanged water at 25° C., stirred and dissolved, and then left to stand for 24 hours at 25° C. As a result, neither separation nor precipitation was observed in these resins, indicating that they were completely soluble and water-soluble.
[0070] <Preparation of cell culture medium additives> The water-soluble vinyl polymer (a) from which the solvent was evaporated was dissolved in phosphate buffered saline (hereinafter, PBS solution) to obtain a cell culture medium additive of Production Example 14 having a concentration of 10% by mass.
[0071] [Examples 15-19] A vinyl polymer was obtained with the composition shown in Table 2, and the moiety derived from the monomers (A4) to (A6) in the vinyl polymer was reacted with a betaining agent (D) to synthesize a water-soluble vinyl polymer (a), which was then dissolved in a PBS solution to obtain cell culture medium additives of Production Examples 15 to 19. The reaction formulae between the moiety derived from the monomers (A4) to (A6) in the vinyl polymer and the betaining agent (D) are shown in the following formulae 11 to 15. As a result of this reaction, it is found that the water-soluble vinyl polymer (a) has a betaine structure in the side chain.
[0072] [ka]
[0073] [ka]
[0074] [ka]
[0075] [ka]
[0076] [ka]
[0077] [Table 2]
[0078] The symbols in the table are as follows: DM: N-methacryloyloxyethyl-N,N-dimethylamine VI: 1-Vinylimidazole VP: 2-vinylpyridine BS: 1,4-butane sultone PS: 1,3-propane sultone SBS: Sodium 4-bromobutanesulfonate PL: β-propiolactone SC: Sodium chloroacetate
[0079] [evaluation] The obtained cell culture medium additive was evaluated as follows, and the results are shown in Table 3. The following (1) evaluation of cell medium additives, (2) evaluation of production amount of physiologically active substances, and (3) evaluation of cell activity and spheroid formation were performed by adding a specified amount of cell medium additives to each basal medium and adjusting the medium composition by pipetting, and evaluating the final concentration range of 0.01% to 1% by mass.
[0080] (1) Evaluation of cell culture medium additives
[0081] <Cytotoxicity evaluation> A medium was prepared by adding 10% fetal bovine serum (FBS) to a low glucose-DMEM medium (Sigma-Aldrich) (hereinafter, the above medium is referred to as 10% FBS-DMEM medium). A cell medium additive containing a water-soluble vinyl polymer was added to the 10% FBS-DMEM medium to the concentration shown in Table 3, and the medium composition was prepared by stirring. Human liver cancer cell line HepG2 cells were adjusted to 100,000 cells / mL, and then seeded into the wells of a 96-well flat-bottom microplate at 100 μL per well. The plate was then cultured for 2 days in a stationary state in a CO2 incubator (37°C, 5% CO2). The medium was then replaced with the above medium composition containing the cell medium additive containing a water-soluble vinyl polymer, and after one day of culture, a cytotoxicity test using WST-8 reagent was evaluated. After adding 10 μL of WST-8 reagent (Dojin Laboratories, Inc.) to the culture medium containing the cultured hepatocytes, the cells were allowed to stand in a CO2 incubator (37°C, 5% CO2) for 2 hours. After 2 hours, the absorbance at 450 nm was measured using a microplate reader, and the cytotoxicity was evaluated by subtracting the absorbance of the culture medium to which the WST-8 reagent had not been added. The results were evaluated as a relative value, with the results of culture without the addition of a cell medium additive containing a water-soluble vinyl polymer being taken as 1. The evaluation results are shown in Table 3. ◎: 1.0 or more (very good) ○: 0.90 or more to less than 1.0 (good) ×: Less than 0.90 (bad)
[0082] (2) Evaluation of production amount of biologically active substances
[0083] <Antibody productivity evaluation> The medium used was Dynamis Medium (Gibco), and L-Glutamin was added to 1.0% by mass. Hereinafter, this is referred to as the basal medium. Two sets of this were prepared, and the obtained cell medium additive containing a water-soluble vinyl polymer was added to the concentration shown in Table 3. A CHO cell line (ATCC CRL-12455) that secretes and produces IgG antibodies by introducing an IgG gene into two types of medium with different concentrations of cell medium additive containing a water-soluble vinyl polymer was added to prepare a cell suspension with a CHO cell line concentration of 1,000,000 cells / mL. 20 mL of the obtained cell suspension was seeded in a 125 mL Erlenmeyer flask and cultured at 37°C. During the culture, 15 mL of the supernatant was collected once every 3 to 4 days before the nutrient source was depleted, and replaced with 15 mL of new basal medium, and this was repeated five times. The cell culture solution after the medium replacement was repeated five times was centrifuged to collect the medium supernatant. The amount of antibody in the medium was measured using a Human IgG ELISA Quantitation Set manufactured by Bethyl Laboratories, Inc. The amount of DNA in the precipitated cell group was also quantified and calculated as the amount of antibody produced per unit amount of DNA. The results were evaluated as a relative value, with the results when cultured without adding a cell medium additive containing a water-soluble vinyl polymer being taken as 1. The evaluation results are shown in Table 3. ◎: 1.2 or more (very good) ○: 1 or more to less than 1.2 (good) ×: Less than 1 (bad)
[0084] <Albumin production evaluation> A medium composition was prepared by adding a water-soluble vinyl polymer-containing cell medium additive to a 10% FBS-DMEM medium to the concentration shown in Table 3 and stirring. Human hepatoma cell line HepG2 cells were seeded with the medium composition containing the water-soluble vinyl polymer-containing cell medium additive to give a concentration of 250,000 cells / mL, and then dispensed into wells of a 96-well U-bottom microplate at 200 μL per well. The plate was then cultured for 3 days in a stationary state in a CO2 incubator (37°C, 5% CO2). The culture solution containing the hepatocytes after 3 days of culture was collected and centrifuged to collect the medium supernatant. The amount of albumin in the medium was measured using an Albumin ELISA Quantitation Set manufactured by Bethyl Laboratories, Inc. The amount of DNA in the precipitated cell group was also quantified and calculated as the amount of albumin produced per unit amount of DNA. The results were determined as a relative value when the results of culture without the addition of a water-soluble vinyl polymer-containing cell medium additive were set at 1. The evaluation results are shown in Table 3. ◎: 1.2 or more (very good) ○: 1 or more to less than 1.2 (good) ×: Less than 1 (bad)
[0085] <Evaluation of drug metabolizing enzyme activity> A cell culture medium additive containing a polymer was added to 10% FBS-DMEM medium at the concentrations shown in Table 3, and the medium composition was prepared by stirring. After seeding human hepatocellular carcinoma cell line HepG2 cells in the medium composition added with the cell culture medium additive containing the above water-soluble vinyl polymer at a density of 250,000 cells / mL, it was dispensed into each well of a 96-well U-bottom microplate at 200 μL per well. Then, the plate was cultured in a CO2 incubator (37 °C, 5% CO2) in a static state for 3 days. After culturing for 3 days, the activity of drug-metabolizing enzymes was evaluated. The activity of drug-metabolizing enzymes was evaluated using P450-GloTM CYP3A4 Assay Kits (manufactured by Promega), and Luciferin-IPA was used as a substrate. The medium containing the substrate was replaced with 10% FBS-DMEM medium and incubated for 4 hours. The incubated medium was transferred to a black plate for luminescence measurement, a detection reagent (Luciferin detection reagent) was added, and it was left standing at room temperature for 20 minutes. The amount of luminescence of this plate was measured using a plate reader (manufactured by Berthold). Also, the DNA amount of the cell group was quantified and calculated as the activity value of drug-metabolizing enzymes per unit DNA amount. The results were judged as relative values with the results of culturing without adding the cell culture medium additive containing the water-soluble vinyl polymer set as 1. The evaluation results are shown in Table 3. ◎: 1.2 or more (very good) ○: 1.0 or more and less than 1.2 (good) ×: less than 1 (poor)
[0086] <Gene expression analysis by qRT-PCR method> A cell culture medium additive containing a polymer was added to 10% FBS-DMEM medium at the concentrations shown in Table 3, and the medium composition was prepared by stirring. Human hepatocellular carcinoma cell line HepG2 cells were seeded at a density of 250,000 cells / mL in the medium composition supplemented with the cell culture medium additive containing the above water-soluble vinyl polymer, and then dispensed into the wells of a 96-well U-bottom microplate at 200 μL per well. Thereafter, the plate was cultured in a CO2 incubator (37 °C, 5% CO2) in a static state for 3 days. The culture solution containing hepatocytes after 3 days of culture was collected, and the cells were collected by centrifugation. Total RNA was extracted from the collected HepG2 cells using the RNeasy Micro Kit (QIAGEN). cDNA was synthesized from the extracted total RNA by reverse transcription reaction using ReverTra Ace qPCR RT Master Mix (TOYOBO). qRT-PCR was performed using the cDNA and TaqMan probes for the target genes (CYP3A4 and Albumin) (manufactured by Life Technologies, CYP3A4: Hs00604506_m1, Albumin: Hs00609411_m1). GAPDH (manufactured by Life Technologies, Hs02786624_g1) was used as the reference gene. The relative expression levels of each gene were calculated using the comparative Ct method based on GAPDH. The results were judged as relative values with the performance when cultured without adding the cell culture medium additive containing the water-soluble vinyl polymer set as 1. The evaluation results are shown in Table 3. ◎: 2 or more (very good) ○: 1 or more and less than 2 (good) ×: less than 1 (poor)
[0087] (3) Evaluation of cell activity and spheroid formation ability
[0088] <ATP activity> A medium composition was prepared by adding a cell medium additive containing a water-soluble vinyl polymer to a 10% FBS-DMEM medium to the concentration shown in Table 3 and stirring. Human liver cancer cell line HepG2 cells were seeded with the medium composition containing the cell medium additive containing the water-soluble vinyl polymer so that the cell concentration was 100,000 cells / mL, and then dispensed into wells of a 96-well U-bottom microplate at 100 μL per well. The plate was then cultured in a stationary state in a CO2 incubator (37°C, 5% CO2) for 5 days. ATP activity was evaluated by ATP assay after 1 and 5 days. Specifically, 100 μL of ATP reagent ("clump" ATP measurement reagent: manufactured by Toyo B-Net) was added to the wells after incubation, pipetted 5 times, and left to stand at room temperature for 5 minutes. After that, 100 μL of the reagent and cell lysate were dispensed onto a separate plate and stirred for 1 minute. The luminescence intensity was measured using Mithras LB940 (manufactured by Berthold). The evaluation results are shown in Table 3. ATP activity = (luminescence amount after 5 days of culture) / (luminescence amount after 1 day of culture) x 100 ◎: ATP activity 120% or more, ATP activity is quite high (very good) 〇: 50%≦ATP activity<120% ATP activity is high (good) △: 20%≦ATP activity<50% ATP activity is slightly high (passable) ×: ATP activity <20% ATP activity is low (poor)
[0089] <Spheroid formation> A medium composition was prepared by adding a cell medium additive containing a water-soluble vinyl polymer to a 10% FBS-DMEM medium to the concentration shown in Table 3 and stirring. A human liver cancer cell line (HepG2 cells) was seeded with the medium composition containing the cell medium additive containing the water-soluble vinyl polymer so that the cell concentration was 100,000 cells / mL, and then dispensed into the wells of a microplate (Sumitomo Berakuit Co., Ltd. PrimeSurfaceMS-9096U) at 100 μL per well. The plate was then cultured in a stationary state in a CO2 incubator (37°C, 5% CO2) for 3 days. The spheroid forming ability was evaluated based on the following criteria by photographing the cell culture state after 3 days using a transmission optical microscope at 40x magnification and observing the cell morphology. The evaluation results are shown in Table 3. 〇: One spheroid formed (good) △: Multiple spheroids formed (slightly poor) ×: No spheroids formed (defective)
[0090] [Table 3]
[0091] <Result> From the results in Table 3, it was found that the cell culture medium additives of Examples 1 to 19 had low cytotoxicity and exhibited excellent antibody productivity, albumin productivity, and drug metabolizing enzyme activity. On the other hand, the additives of Comparative Examples 1 to 4 were inferior to the cell culture additives of Examples 1 to 19 in terms of cytotoxicity, antibody productivity, albumin productivity, and ATP activity. [Industrial Applicability]
[0092] The cell culture medium additive of the present invention can increase the production amount of a physiologically active substance by adding it to a cell culture medium. In addition, the use of the cell culture medium additive of the present invention is useful in that it can promote the productivity of a desired physiologically active substance and reduce production costs and labor. For example, it can greatly contribute to the mass supply of biopharmaceuticals such as antibody drugs.
Claims
1. A cell culture medium additive comprising a water-soluble vinyl polymer (a) having a structural unit represented by the following general formula 1 in a side chain (excluding polymers having a polyoxyalkylene group in a side chain, the end of which is a repeating unit composed of an alkyl group having 5 to 30 carbon atoms, an alkanoyl group having 5 to 30 carbon atoms, or an aryl group having 6 to 30 carbon atoms): the water-soluble vinyl polymer (a) contains 30 to 100% by mass of a structural unit represented by the following general formula 1, relative to 100% by mass of the total of the monomer units constituting the water-soluble vinyl polymer (a): A cell culture medium additive, characterized in that the water-soluble vinyl polymer (a) is the following (a1) or (a2): (a1) A copolymer of monomers containing a monomer (A1) represented by the following general formula 4: (a2) A reaction product of a copolymer of a monomer containing a monomer (A4) represented by the following general formula 7 and one or more betaining agents (D) selected from the group consisting of a cyclic sulfonate ester (D1), an ω-halogenated alkylsulfonic acid metal salt (D2), a cyclic carboxylic acid ester (D3), and an ω-halogenated alkylcarboxylic acid metal salt (D4). 【Chemical 1】 (In general formula 1, R 2 is an alkylene group having 1 to 6 carbon atoms, R 3 , R 4 each independently represents an alkyl group having 1 to 4 carbon atoms, R 5 is an alkylene group having 1 to 4 carbon atoms, X is an oxygen atom or —NH—; Y is -COO - or -SO 3 - represents * indicates the bonding position with the main chain of the vinyl polymer.) 【Chemistry 2】 【Chemistry 3】 (In general formulas 4 and 7, R 1 represents a hydrogen atom or a methyl group; R 2 is an alkylene group having 1 to 6 carbon atoms; R 3 and R 4 each independently represent an alkyl group having 1 to 4 carbon atoms; R 5 is an alkylene group having 1 to 4 carbon atoms; X is an oxygen atom or —NH—; Y represents —COO − or —SO 3 − ; ** represents the reaction site with the betaining agent (D).
2. The cell culture medium additive according to claim 1, wherein the water-soluble vinyl polymer (a) contains 30 to 95% by mass of the structural unit represented by general formula 1 relative to 100% by mass of the total of the monomer units constituting the water-soluble vinyl polymer (a).
3. 3. The cell culture medium additive according to claim 1, wherein the water-soluble vinyl polymer (a) comprises structural units based on a monomer (B) having a partition coefficient Log P of 0.8 to 10, and the structural units based on the monomer (B) account for 5 to 70% by mass relative to 100% by mass of the total monomer units constituting the water-soluble vinyl polymer (a).
4. A cell culture medium comprising the cell culture medium additive according to any one of claims 1 to 3, A cell culture medium, wherein the concentration of the water-soluble vinyl polymer (a) in the culture medium is 0.001 to 1% by mass.
5. A method for producing spheroids or physiologically active substances, comprising culturing cells in the cell culture medium according to claim 4.
Citation Information
Patent Citations
JP1974061133A
Method of detecting mark in charged beam lithography
JP1988053923A
Composition for animal cell culture, culturing method and production of physiologically active substance
JP1992304882A
Synthetic medium for production of valuable substance
JP1995023780A
Medical material
JP2007130194A
